Most COVID-19 Patients Admitted to ICU Still Experience Symptoms 1 Year Later

Article

Nearly 75% of COVID-19 patients admitted to the ICU were symptomatic 1 year later, most commonly reporting weakened condition and musculoskeletal problems.

Nearly 75% of COVID-19 patients admitted to the ICU were symptomatic 1 year later, most commonly reporting weakened condition and musculoskeletal problems.

The COVID-19 pandemic caused many patients to fall critically ill and require treatment in an intensive care unit (ICU). Even a year later, the ICU patients who survived COVID-19 commonly experience physical, mental, and cognitive symptoms.

The exploratory prospective multicenter cohort study was conducted in the ICUs of 11 Dutch hospitals and published today in the Journal of the American Medical Association (JAMA). Investigators included 452 patients aged 16 and older who survived ICU admission during the first COVID-19 surge (March 1-July 1, 2020). The patients were followed up for 1 year following their release from the ICU, and the final follow-up date was June 16, 2021.

The main outcomes were physical symptoms (including frailty, fatigue, and other physical problems), mental symptoms (anxiety, depression, PTSD), and cognitive symptoms self-reported 1 year after ICU treatment.

Of the initial patient cohort, 301 (66.8%) were included in the study. The average age was 61.2 years, the average duration of ICU stay was 18 days, and 71.5% were male. A year after their release from the ICU, 74.3% of patients reported physical symptoms, 26.2% reported mental symptoms, and 16.2% reported cognitive symptoms.

The most commonly reported new physical problems were weakened condition (38.9%), joint stiffness (26.3%), joint pain (25.5%), muscle weakness (24.8%), and myalgia (21.3%).

The respondents indicated that their continued COVID-19 symptoms make it difficult to go about their day-to-day lives, with 58% of ICU survivors saying they had problems returning to work.

This frequency of symptoms 1 year after recovering from severe COVID-19 disease is concerning, as much is still unknown about “long covid” and the long-term health impact of COVID-19 infection.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.